MSD
HHS to fund production of MSD’s Ebola vaccine V920
August 22, 2019Manufacturing and Production Ebola, HHS, MSD, Vaccine, pharma
The US Department of Health and Human Services (HHS) has said it will fund the production of MSD’s investigational Ebola …
Lynparza extends progression-free survival in first-line advanced ovarian cancer, with or without BRCA mutations
August 14, 2019Research and Development AstraZeneca, Cancer, MSD, lynparza, ovarian cancer, pharma
New Phase 3 data has emerged on AstraZeneca and MSD’s Lynparza (olaparib), showing that the PARP inhibitor achieved its primary …
MSD teams up with Harvard University to discover novel immune system pathways to fight cancer
August 13, 2019Manufacturing and Production, Research and Development Cancer, Harvard, MSD, Merck, immuno-oncology, oncology, pharma
A new partnership between MSD and Harvard University hopes to combine the expertise of both parties to carve a path …
Keytruda/chemo combo recommended for first-line lung cancer via Cancer Drugs Fund
August 8, 2019Sales and Marketing CDF, Cancer, MSD, NHS, NICE, UK, keytruda, lung cancer, pharma
MSD’s Keytruda (pembrolizumab) has secured recommendation from NICE for inclusion on the Cancer Drugs Fund (CDF) in combination with chemotherapy …
MSD to bring over 400 new jobs to North Carolina with two site expansions
July 31, 2019Manufacturing and Production, Research and Development MSD, US, pharma
MSD has announced a $650 million expansion of its existing facilities in North Carolina – a move which is bring …
MSD’s Keytruda combo hits primary endpoint at Phase 3 in triple-negative breast cancer
July 30, 2019Manufacturing and Production, Research and Development Cancer, MSD, breast cancer, keytruda, pharma
MSD’s blockbuster anti-PD-L1 immunotherapy Keytruda (pembrolizumab) has impressed in newly released Phase 3 data; the company announced that, when combined …
Humira biosimilar from Samsung Bioepis and MSD wins marketing authorisation in the US
July 24, 2019Research and Development, Sales and Marketing AbbVie, Humira, MSD, Samsung Bioepis, biosimilars, pharma
It’s another victory for MSD as the US drugmaker announced that its biosimilar version of AbbVie’s Humira – the world’s …
MSD trials long lasting PrEP implant for preventing HIV
July 23, 2019Research and Development AIDS, HIV, MSD, PrEP, pharma
MSD is trialling an implant that prevents patients from contracting HIV, The Guardian has said. The US firm has tested …
FDA approves MSD’s combo therapy Recarbrio for urinary tract and intra-abdominal infections
July 18, 2019Sales and Marketing FDA, MSD, Recarbrio, US, pharma, urinary tract
MSD has announced the approval from the FDA of its combination therapy Recarbrio (imipenem, cilastatin and relebactam) in the treatment …
US Judge blocks Trump administration law requiring pharma to include prices in TV ads
July 9, 2019Manufacturing and Production Amgen, Eli Lilly, MSD, TV ads, Trump, USA, court, pharma
A judge has blocked the Trump administration from enacting a law that would require pharmaceutical companies to include the prices …
Top Ten most popular articles on Pharmafile.com this week
June 21, 2019Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing FDA, GSK, MSD, Parkinson's, blockchain, brexit, top ten
It’s Friday, and time for another run-down of the week’s most popular articles.
MSD’s Keytruda snatches up first approval in small cell lung cancer
June 19, 2019Research and Development, Sales and Marketing Cancer, FDA, MSD, US, keytruda, lung cancer, pharma
MSD has revealed that its anti-PD-1 immunotherapy Keytruda (pembrolizumab) has been awarded marketing authorisation from the FDA as a monotherapy …
EU approval for MSD and AZ’s Lynparza in first-line BRCA-mutated advanced ovarian cancer
June 18, 2019Manufacturing and Production, Sales and Marketing AstraZeneca, Cancer, MSD, lynparza, ovarian cancer, pharma
AstraZeneca and MSD’s jointly-developed therapy Lynparza (olaparib) has scored its third EU approval, the pair announced, with authorisation for the …
Drugmakers sue Trump over prices in TV ads
June 17, 2019Sales and Marketing Amgen, Eli Lilly, HHS, MSD, Merck, Trump, pharma
Amgen, Eli Lilly and MSD have sued the Trump administration to try and block measures to force pharma companies to …
FDA ask MSD to join blockchain supply chain network
June 14, 2019Medical Communications FDA, MSD, Merck, blockchain, supply chain
The FDA has asked MSD to join a shared permission blockchain network to help track and trace prescription medicines and …
Latest content
Pharma sees climate disruption as growing supply-chain risk
Manchester NHS-MHRA partnership to test new technologies in real-world care
